Item 9A. Controls and Procedures
ITEM 9A. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Our disclosure controls and procedures are designed to ensure that information we are required to disclose in reports that we file or submit under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
Our management, with the participation and supervision of our Chief Executive Officer (our principal executive officer) and our Chief Financial Officer (our principal financial officer), has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of December 31, 2025 . Based on such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of December 31, 2025 , our disclosure controls and procedures were, in design and operation, effective at a reasonable assurance level.
Management’s Report on Internal Control Over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) and 15(d)-15(f) under the Exchange Act) to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Our management, under the supervision of our Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the effectiveness of our internal control over financial reporting based on the criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring
167
Organizations of the Treadway Commission. Based on this evaluation, our management has concluded that our internal control over financial reporting was effective as of December 31, 2025 .
Excluded from our evaluation were internal controls over financial reporting at Sentillia B.V., for which control was acquired on August 14, 2025. The financial statements of this entity constitute less than 1% of total assets and 2% of total revenue as of and for the year ended December 31, 2025, respectively.
The effectiveness of our internal control over financial reporting as of December 31, 2025 has been audited by Deloitte & Touche LLP, an independent registered public accounting firm, as stated in their report, which is included in Part II, Item 8 of this Annual Report on Form 10-K.
Changes in Internal Controls Over Financial Reporting
There were no changes to our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Inherent Limitations on the Effectiveness of Controls
The effectiveness of any system of internal control over financial reporting, including ours, is subject to inherent limitations, including the exercise of judgment in designing, implementing, operating, and evaluating the controls and procedures, and the inability to eliminate misconduct completely. Accordingly, in designing and evaluating the disclosure controls and procedures, management recognizes that any system of internal control over financial reporting, including ours, no matter how well designed and operated, can only provide reasonable, not absolute assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs. Moreover, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. We intend to continue to monitor and upgrade our internal controls as necessary or appropriate for our business but cannot assure you that such improvements will be sufficient to provide us with effective internal control over financial reporting.
ITEM 9B. OTHER INFORMATION
Rule 10b5-1 Trading Plans
The Company’s directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) are only permitted to trade in the Company’s securities pursuant to a prearranged trading plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act (a “Rule 10b5-1 Plan”). During the three months ended December 31, 2025, one of the Company’s officers adopted a Rule 10b5-1 Plan, which was entered into during an open trading window in accordance with the Company’s Insider Trading Policy and Trading Plan Policy.
On December 3, 2025 , Lawrence Brock , the Company’s Chief People Officer , entered into a Rule 10b5-1 Plan (the “Brock Plan”) providing for the potential sale of up to 86,393 shares of Class A common stock owned by Mr. Brock, plus an additional undetermined number of shares of Class A common stock to be received by Mr. Brock upon the future grant, vesting, and settlement of RSUs for shares of Class A common stock, including upon the vesting and settlement of RSUs for shares of Class A common stock and the exercise of vested stock options for shares of Class A common stock, so long as the market price of the Class A common stock is higher than certain minimum threshold prices specified in the Brock Plan or, in certain circumstances, at the market price, between an estimated start date of March 4, 2026 and May 28, 2027 . The Brock Plan provides for the sale of shares of Class A common stock to be received by Mr. Brock upon the future grant, vesting, and settlement of RSUs for shares of Class A common stock.
168
The Brock Plan also provides for the sale of shares of Class A common stock to be received upon the future vesting and settlement of certain outstanding RSUs, net of any shares withheld or mandatorily sold by the Company to satisfy applicable tax obligations and shares sold pursuant to Mr. Brock’s prior Rule 10b5-1 Plan dated December 2, 2024 (the “Prior Brock Plan”). The numbers of shares (i) to be received by Mr. Brock upon the future grant, vesting, and settlement of RSUs for shares of Class A common stock and (ii) to be withheld or mandatorily sold by the Company or sold pursuant to the Prior Brock Plan, and therefore the exact number of shares to be sold pursuant to the Brock Plan, can only be determined upon the occurrence of the future vesting events. For purposes of this disclosure, we have included the maximum aggregate number of shares to be sold without (i) including any shares to be sold upon the future vesting and settlement of any RSUs that have not yet been granted and (ii) subtracting any shares to be withheld or mandatorily sold by the Company upon future vesting events or to be sold pursuant to the prior Brock Plan.
ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS
Not applicable
PART III I
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
The information required by this item is incorporated by reference to the definitive Proxy Statement for our 2026 Annual Meeting of Shareholders, which will be filed with the SEC no later than 120 days after December 31, 2025 .
Insider Trading Policies and Procedures
The Company has insider trading policies and procedures that govern the purchase, sale, and other dispositions of its securities by directors, officers, employees, contractors, advisors, and consultants, and the Company itself, that the Company believes are reasonably designed to promote compliance with insider trading laws, rules and regulations and the listing standards of Nasdaq. A copy of the Company’s Insider Trading Policy is filed with this Annual Report on Form 10-K as Exhibit 19.1.
ITEM 11. EXECUTIVE COMPENSATION
The information required by this item is incorporated by reference to the definitive Proxy Statement for our 2025 Annual Meeting of Shareholders, which will be filed with the SEC no later than 120 days after December 31, 2025 .
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS
The information required by this item is incorporated by reference to the definitive Proxy Statement for our 2026 Annual Meeting of Shareholders, which will be filed with the SEC no later than 120 days after December 31, 2025 .
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
The information required by this item is incorporated by reference to the definitive Proxy Statement for our 2026 Annual Meeting of Shareholders, which will be filed with the SEC no later than 120 days after December 31, 2025 .
ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
The information required by this item is incorporated by reference to the definitive Proxy Statement for our 2026 Annual Meeting of Shareholders, which will be filed with the SEC no later than 120 days after December 31, 2025 .
169
PART IV
ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
1. Financial Statements
The following financial statements are included in Part II, Item 8 of this Annual Report on Form 10-K:
Reports of Independent Registered Public Accounting Firm
Consolidated Balance Sheets
Consolidated Statements of Operations
Consolidated Statements of Comprehensive Income
Consolidated Statements of Changes in Shareholders’ Equity
Consolidated Statements of Cash Flows
Notes to the Consolidated Financial Statements
2. Financial Statement Schedules
All schedules have been omitted because the required information is included in the Consolidated Financial Statements or the notes thereto, or because it is not required.
3. Exhibits
The exhibits listed below are filed as part of this Annual Report on Form 10-K or are incorporated herein by reference, in each case as indicated below.
Incorporated by Reference Filed or Furnished Herewith
Exhibit
Number Description Form File No. Exhibit Filing Date
2.1
Share Purchase Agreement, dated as of May 8, 2025, by and among Coinbase Global, Inc, Sentillia B.V., the Deribit Shareholders listed on Exhibit B thereto and Shareholder Representative Services LLC as the shareholders’ agent
8-K
001-40289
2.1
5/8/2025
3.1
Certificate of Formation
8-K
001-40289
3.1
12/15/2025
3.2
Bylaws
8-K
001-40289
3.2
12/15/2025
4.1
Form of the Registrant’s Class A common stock certificate
X
4.2
Amended and Restated Investors’ Rights Agreement by and between the Registrant and certain securityholders dated March 15, 2021
S-1
333-253482
4.2
3/17/2021
4.3
Indenture, dated as of May 21, 2021, between Coinbase Global, Inc. and U.S. Bank National Association, as trustee
8-K
001-40289
4.1
5/21/2021
4.4
Form of 0.50% Convertible Senior Notes due 2026 (included in Exhibit 4.3)
8-K
001-40289
4.2
5/21/2021
4.5
First Supplemental Indenture, dated as of December 12, 2025, between Coinbase Global, Inc. and U.S. Bank National Association, as trustee (2026 Notes)
8-K
001-40289
4.1
12/16/2025
4.6
Indenture, dated as of September 17, 2021, between Coinbase Global, Inc. and U.S. Bank National Association, as trustee
8-K
001-40289
4.1
9/17/2021
170
4.7
Form of 3.375% Senior Notes due 2028 (included in Exhibit 4.6)
8-K
001-40289
4.2
9/17/2021
4.8
Form of 3.625% Senior Notes due 2031 (included in Exhibit 4.6)
8-K
001-40289
4.3
9/17/2021
4.9
Indenture, dated as of March 18, 2024, between Coinbase Global, Inc. and U.S. Bank Trust Company, National Association, as trustee
8-K
001-40289
4.1
3/18/2024
4.10
Form of 0.25% Convertible Senior Notes due 2030 (included in Exhibit 4.9)
8-K
001-40289
4.2
3/18/2024
4.11
First Supplemental Indenture, dated as of December 12, 2025, between Coinbase Global, Inc. and U.S. Bank National Association, as trustee (2030 Notes)
8-K
001-40289
4.3
12/16/2025
4.12
Indenture, dated as of August 8, 2025, between Coinbase Global, Inc. and U.S. Bank Trust Company, National Association, as trustee
8-K
001-40289
4.1
8/8/2025
4.13
Form of 0% Convertible Senior Notes due 2029 (included in Exhibit 4.1 2 )
8-K
001-40289 4.2
8/8/2025
4.14
First Supplemental Indenture, dated as of December 12, 2025, between Coinbase Global, Inc. and U.S. Bank National Association, as trustee (2029 Notes)
8-K
001-40289
4.2
12/16/2025
4.15
Indenture, dated as of August 8, 2025, between Coinbase Global, Inc. and U.S. Bank Trust Company, National Association, as trustee
8-K
001-40289 4.3
8/8/2025
4.16
Form of 0% Convertible Senior Notes due 2032 (included in Exhibit 4. 12 )
8-K
001-40289 4.4
8/8/2025
4.17
First Supplemental Indenture, dated as of December 12, 2025, between Coinbase Global, Inc. and U.S. Bank National Association, as trustee (2032 Notes)
8-K
001-40289
4.4
12/16/2025
4.18
Description of Class A common stock registered under Section 12 of the Securities Exchange Act of 1934, as amended
X
10.1
Form of Indemnification Agreement by and between the Registrant and each of its directors and executive officers
X
10.2† 2013 Amended and Restated Stock Plan and forms of award agreements thereunder
S-1
333-253482
10.2
2/25/2021
10.3†
2019 Equity Incentive Plan, as amended, and forms of award agreements thereunder
S-1
333-253482
10.3
2/25/2021
10.4†
2021 Equity Incentive Plan and forms of award agreements thereunder
X
10.5†
2021 Employee Stock Purchase Plan and forms of enrollment agreements thereunder
10-K 001-40289 10.5 2/13/2025
10.6†
Form of Immediately Exercisable Stock Option Agreement under the 2021 Equity Incentive Plan
10-K
001-40289 10.6
2/25/2022
10.7†
Employment Agreement by and between the Registrant and Brian Armstrong, dated February 18, 2021
S-1
333-253482
10.6
2/25/2021
171
10.8†
Employment Agreement by and between the Registrant and Paul Grewal, dated February 11, 2021
S-1
333-253482
10.8
2/25/2021
10.9†
Employment Agreement by and between the Registrant and Alesia J. Haas, dated March 29, 2021
10-K
001-40289
10.10
2/25/2022
10.10†
Employment Agreement by and between the Registrant and Emilie Choi, dated April 8, 2021
10-K
001-40289
10.11
2/25/2022
10.11†
Employment Agreement by and between the Registrant and Lawrence Brock, dated February 11, 2023
10-K
001-40289
10.11
2/15/2024
10.12†
Amended and Restated Change of Control and Severance Policy
X
10.13
Form of Capped Call Transaction Confirmation relating to 0.50% Convertible Senior Notes due 2026
8-K
001-40289
10.1
5/21/2021
10.14
Form of Capped Call Transaction Confirmation relating to 0.25% Convertible Senior Notes due 2030
8-K
001-40289
10.1
3/18/2024
10.15
Form of Capped Call Transaction Confirmation relating to 0% Convertible Senior Notes due 2029 and 0% Convertible Senior Notes due 2032
8-K
001-40289
10.1
8/8/2025
10.16*^
Collaboration Agreement by and between the Registrant and Circle Interest Financial, LLC, dated August 18, 2023
X
10.17*^
Stablecoin Ecosystem Agreement by and between the Registrant and Circle Interest Financial, LLC, dated November 14, 2024
10-K
001-40289
10.16
2/13/2025
18.1
Preferability Letter of Deloitte & Touche LLP regarding change in accounting principle
X
19.1
Insider Tradi ng Policy
X
21.1
List of Subsidiaries of the Registrant
X
23.1
Consent of Deloitte & Touche LLP, independent registered pub lic accounting firm
X
24.1
Power of Attorney (included on the signature page of this Annual Report on Form 10-K)
X
31.1 Certification of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
X
31.2 Certification of Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
X
32.1
Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
X
172
32.2
Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
X
97.1
Compensation Recovery Policy
X
101.INS Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document) X
101.SCH Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents X
104 Cover Page Interactive Data File - the cover page from the registrant’s Annual Report on Form 10-K for the year ended December 31, 2025 is formatted as Inline XBRL and contained in Exhibit 101
X
† Indicates a management or compensatory plan or arrangement in which directors or executive officers are eligible to participate.
* The Registrant has omitted portions of the exhibit (indicated by “[*]”) as permitted under Item 601(b)(10)(iv) of Regulation S-K, which portions will be furnished to the SEC upon request.
^ The Registrant has omitted schedules and exhibits pursuant to Item 601(a)(5) of Regulation S-K. The Registrant agrees to furnish supplementally a copy of the omitted schedules and exhibits to the SEC upon request.
The certifications furnished in Exhibits 32.1 and 32.2 hereto are deemed to accompany this Annual Report on Form 10-K and are not deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall they be deemed incorporated by reference into any filing under the Securities Act of the Exchange Act.
ITEM 16. FORM 10-K SUMMARY
None
173
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized.
COINBASE GLOBAL, INC.
Date: February 12, 2026
By: /s/ Brian Armstrong
Brian Armstrong
Chief Executive Officer and Director
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Brian Armstrong and Alesia J. Haas, and each of them, as his or her true and lawful attorneys-in-fact, proxies, and agents, each with full power of substitution, for him or her in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact, proxies, and agents full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact, proxies, and agents, or their or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Annual Report on Form 10-K has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
174
Name Title Date
/s/ Brian Armstrong Chief Executive Officer and Chairman of the Board February 12, 2026
Brian Armstrong (Principal Executive Officer)
/s/ Alesia J. Haas Chief Financial Officer February 12, 2026
Alesia J. Haas (Principal Financial Officer)
/s/ Jennifer N. Jones Chief Accounting Officer February 12, 2026
Jennifer N. Jones (Principal Accounting Officer)
/s/ Marc L. Andreessen Director February 12, 2026
Marc L. Andreessen
/s/ Paul Clement
Director February 12, 2026
Paul Clement
/s/ Christa Davies
Director February 12, 2026
Christa Davies
/s/ Frederick Ernest Ehrsam III Director February 12, 2026
Frederick Ernest Ehrsam III
/s/ Kelly Kramer Director February 12, 2026
Kelly Kramer
/s/ Chris Lehane
Director February 12, 2026
Chris Lehane
/s/ Tobias Lütke Director February 12, 2026
Tobias Lütke
/s/ Gokul Rajaram Director February 12, 2026
Gokul Rajaram
/s/ Fred Wilson Director February 12, 2026
Fred Wilson
175